Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPPH PDT for Obstructing Endobronchial Lung Cancer
NCT00528775Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Aug 2007
- Primary completion
- Nov 2009
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of hpph in non-small cell lung cancer (NSCLC), sponsored by Roswell Park Comprehensive Cancer Center. Started Aug 2007; status: terminated.
02
Drugs
hpph
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00528775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528775.